Stoke Therapeutics, Inc. — Form D

Stoke Therapeutics, Inc. of Bedford, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-24. The offering totals $850K, of which $850K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Isabel AznarezDirectorCold Spring Harbor, NY
Adrian KrainerDirectorCold Spring Harbor, NY
Isabel AznarezExecutive OfficerCold Spring Harbor, NY
Adrian KrainerExecutive OfficerCold Spring Harbor, NY
Huw NashExecutive OfficerCold Spring Harbor, NY
Isabel AznarezPromoterCold Spring Harbor, NY
Adrian KrainerPromoterCold Spring Harbor, NY
SAMUEL W HALLDirectorNEW YORK, NY
Barry M TichoExecutive OfficerBedford, MA
Charles R AllersonExecutive OfficerBedford, MA
Gene M LiauExecutive OfficerBedford, MA
Adrian R KrainerDirectorBedford, MA
Adrian R KrainerExecutive OfficerBedford, MA
Adrian R KrainerPromoterBedford, MA
Edward M KayeDirectorBedford, MA
Edward M KayeExecutive OfficerBedford, MA
Meena R MeenaExecutive OfficerBedford, MA
Arthur A LevinDirectorBedford, MA
Arthur W TzianabosDirectorBedford, MA
Isabel M AznarezExecutive OfficerBedford, MA
Isabel M AznarezPromoterBedford, MA
Huw M NashExecutive OfficerBedford, MA
Seth L HarrisonDirector

Other filings by this issuer (1)

FiledFormOfferingSold
2018-11-02D$90.0M$90.0M

More